1. Home
  2. GKOS vs SR Comparison

GKOS vs SR Comparison

Compare GKOS & SR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$141.22

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Spire Inc.

SR

Spire Inc.

HOLD

Current Price

$90.50

Market Cap

5.4B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
SR
Founded
1998
1857
Country
United States
United States
Employees
N/A
3497
Industry
Medical/Dental Instruments
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.4B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
SR
Price
$141.22
$90.50
Analyst Decision
Strong Buy
Buy
Analyst Count
12
9
Target Price
$126.92
$91.33
AVG Volume (30 Days)
642.1K
265.1K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
3.68%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$6.81
Revenue Next Year
$27.43
$2.31
P/E Ratio
N/A
$19.47
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$71.24
52 Week High
$145.50
$95.31

Technical Indicators

Market Signals
Indicator
GKOS
SR
Relative Strength Index (RSI) 73.45 47.68
Support Level $80.14 $88.77
Resistance Level N/A $92.20
Average True Range (ATR) 4.95 1.80
MACD 1.69 -0.20
Stochastic Oscillator 86.28 42.75

Price Performance

Historical Comparison
GKOS
SR

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SR Spire Inc.

Spire Inc. is the holding company for Spire Missouri, Spire Alabama, other gas utilities, and gas-related businesses, focused on growing organically, investing in infrastructure, and advancing through innovation. Its three segments are Gas Utility, Gas Marketing, and Midstream. The Gas Utility segment is the core business and includes Spire Missouri, Spire Alabama, and Spire EnergySouth. The Gas Marketing segment includes Spire Marketing, which provides non-regulated natural gas services across the U.S. The Midstream segment includes Spire Storage, Spire STL Pipeline, and Spire MoGas Pipeline. The majority of revenue comes from Gas Utility.

Share on Social Networks: